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Abstract
In 1885, Theodor Escherich first described the Bacillus coli commune, which was subsequently renamed Escherichia coli. We
report the complete genome sequence of this original strain (NCTC 86). The 5 144 392 bp circular chromosome encodes the
genes for 4805 proteins, which include antigens, virulence factors, antimicrobial-resistance factors and secretion systems, of
a commensal organism from the pre-antibiotic era. It is located in the E. coli A subgroup and is closely related to E. coli K-12
MG1655. E. coli strain NCTC 86 and the non-pathogenic K-12, C, B and HS strains share a common backbone that is largely
co-linear. The exception is a large 2 803 932 bp inversion that spans the replication terminus from gmhB to clpB. Comparison
with E. coli K-12 reveals 41 regions of difference (577 351 bp) distributed across the chromosome. For example, and contrary
to current dogma, E. coli NCTC 86 includes a nine gene sil locus that encodes a silver-resistance efflux pump acquired before
the current widespread use of silver nanoparticles as an antibacterial agent, possibly resulting from the widespread use of
silver utensils and currency in Germany in the 1800s. In summary, phylogenetic comparisons with other E. coli strains
confirmed that the original strain isolated by Escherich is most closely related to the non-pathogenic commensal strains. It
is more distant from the root than the pathogenic organisms E. coli 042 and O157 : H7; therefore, it is not an ancestral state
for the species.
DATA SUMMARY
Supplementary figures have been deposited in Figshare
(DOI:10.6084/m9.figshare.4235762) (https://figshare.com/s/
91b570d54d27b0ecf9ea). Supplementary tables are available
with the online Supplementary Material. The genome
sequence of Escherichia coli NCTC 86 has been deposited in
GenBank with project accession number PRJEB14041
(www.ebi.ac.uk/ena/data/view/PRJEB14041) and in EMBL
with accession number LT601384 (https://www.ncbi.nlm.
nih.gov/nuccore/LT601384).
INTRODUCTION
Escherichia coli is unsurpassed as a model organism in the
field of biology. Its leading role is predicated on its ability to
replicate rapidly, to adjust easily to nutritional and environ-
mental changes, and the relative simplicity with which it
can be genetically manipulated. The origin of E. coli as a
model organism began in the early part of the twentieth
century with Charles Clifton’s study of oxidation–reduction
reactions in E. coli K-12 and Felix d’Herelle’s studies on bac-
teriophage interactions with E. coli B [1–3]. However, E. coli
became widely studied after the work of Tatum and Leder-
berg on amino acid biosynthesis and exchange of genetic
material that lead to the award of a Nobel Prize [3]. Subse-
quently, many Nobel Prizes have been awarded for various
studies using this versatile organism.
The depth of knowledge about the biochemistry of E. coli
and the non-pathogenic character of laboratory strains has
made E. coli the workhorse of molecular biology. No other
organism is exploited more widely in research laboratories
to manipulate DNA and to produce native and mutant pro-
teins for studies in a variety of settings. Indeed, Neidhardt’s
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eloquent statement exemplifies the diverse role of E. coli in
research ‘Although not everyone is mindful of it, all cell biolo-
gists have two cells of interest, the one they are studying and
E. coli’ [4]. Therefore, as the biotechnology industry arose
out of the molecular and cell biology research laboratories,
it was logical for E. coli to become the cornerstone of these
revolutionary endeavours. Today, many biopharmaceuticals
are produced in E. coli, and these products impact on the
lives of millions of individuals worldwide on a daily
basis [5].
Whilst E. coli rose to prominence in the twentieth century,
the origin of this organism dates back to the late nineteenth
century. In about 1885, Theodor Escherich (1857–1911)
first described Bacterium coli commune, later named Bacil-
lus coli communis and eventually E. coli in Escherich’s hon-
our after his death [6]. In his initial description, Escherich
made several important observations that are widely
reported in the modern literature, often without supporting
citations. Escherich noted: (i) that the intestinal tracts of
infants were sterile at birth, but were colonized by E. coli
within hours of birth; (ii) that bacterial colonization of the
intestine was attributable to the infant’s environment; (iii)
that E. coli was a Gram-negative, rod-shaped motile organ-
ism; (iv) that E. coli was a dominant member of the micro-
biota; (v) that E. coli produced acid and fermented glucose;
and (vi) that E. coli adopted a commensal lifestyle in the
normal host [7]. Soon after, Escherich and others noted the
pyogenic and pathogenic properties of certain E. coli strains,
although these were predominantly thought to be associated
with individuals whose health was compromised in some
manner. The association of E. coli with urinary tract disease
was observed relatively quickly [8], although it would be
over 50 years before specific diarrhoeal strains of E. coli
were identified [9].
When Theodor Escherich first described his bacillus some
125 years ago, he could not possibly have imagined the major
impact his discovery would have on subsequent generations
of scientists. Even at the time of his death, he could not have
known how E. coli would influence the study of biological sci-
ence. Despite the significance of his discovery, the historically
important strain he isolated has remained largely unstudied.
Here, we present the whole-genome sequence of Escherich’s
original isolate and compare this genome with the genomes of
other pathogenic and commensal E. coli.
METHODS
Bacterial strain and sequencing
The E. coli strain NCTC 86 was isolated in 1885 from a child
with no overt signs of diarrhoeal disease [7]. The strain was
deposited in the National Collection of Type Cultures
(NCTC) in 1919 by the Lister Institute and is officially recog-
nized as Escherich’s original Bacillus coli commune [7]. The
isolate sequenced here was obtained from the UK Health Pro-
tection Agency’s NCTC and is derived from batch 1. DNA
was prepared using Qiagen genomic DNA preparation kits
according to the manufacturer’s instructions. DNA was
fragmented using a Hydroshear (Digilab) using the recom-
mended protocol for 20 kb fragments and further size-selected
on a BluePippin instrument (Sage Science) with a 7 kb mini-
mum size cut-off. The library was sequenced on two SMRT
Cells using the Pacific Biosciences RS II instrument at the
Norwegian Sequencing Centre, Oslo, Norway, using C4-P2
chemistry. The E. coli genome was generated by de novo
assembly using the Pacific Biosciences sequencing data. Reads
were assembled using the ‘RS_HGAP_Assembly.3’ pipeline
within SMRT Portal V2.2.0. Illumina reads from the same
sample were mapped to this draft genome assembly in order
to correct remaining indel errors in the assembly using Pilon
(www.broadinstitute.org/software/pilon).
Gene prediction, annotation and comparative
analysis
Automated annotation was performed using Prokka v1.8
(PMID: 24642063), which uses Prodigal (PMID: 20211023)
for coding sequence prediction, Barrnap (www.vicbioinfor-
matics.com/software.barrnap.shtml) to identify rRNA genes,
Aragorn to identify tRNA genes (PMID: 14704338) and Infer-
nal (PMID: 24008419) to identify non-coding RNA genes. To
assess the size of the core genome and pan-genome of E. coli, a
set of 35 complete E. coli and Shigella genomes was selected. A
pan-genome analysis was performed using Roary v3.7.0
(PMID: 26198102) to determine the sizes of the core and pan-
genomes. A whole-genome phylogeny was reconstructed from
the Roary core genome alignment using RAxML (PMID:
24451623).
Nucleotide sequence accession number
The annotated genome sequence of E. coli NCTC 86 has
been deposited in the EMBL database with the accession
number LT601384.
RESULTS AND DISCUSSION
Structure and general features of the E. coli NCTC
86 chromosome
The E. coli NCTC 86 genome consists of a circular chromo-
some of 5 144 392 bp. The general features of the E. coli
NCTC 86 chromosome are presented in Table 1. We identi-
fied 4805 protein-encoding genes (coding DNA sequences,
IMPACT STATEMENT
This paper is an acknowledgment to one of the fathers of
modern microbiology, Theodor Escherich. Without his
contribution, the shape of the biological field today may
have been an extremely different one. To give another
layer of depth to the story of its origin, we have
sequenced the first isolate of Escherichia coli. The com-
plete genome sequence reveals the genes encoding
the antigens, virulence factors, antimicrobial resistance
and secretion systems of a commensal organism from
the pre-antibiotic era.
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CDSs) in the chromosome, which included 414 (8.62%)that
encoded conserved hypothetical proteins with no known
function and 544 (11.32%) genes associated with mobile ele-
ments such as integrases or transposases, or that were phage
related. We have identified 41 regions of difference (RODs)
in E. coli NCTC 86 compared with other sequenced E. coli
chromosomes (Fig. 1, Table S1, available in the online Sup-
plementary Material). The combined size of these RODs
was 577 351 bp (11.22% of the chromosome). They included
10 prophages distributed across the chromosome (Fig. 1).
Comparison of E. coli NCTC 86 with the non-pathogenic
E. coli K-12, C, B and HS strains revealed that these
genomes shared a common backbone that is largely collin-
ear, with the exception of a 2 803 932 bp inversion (Fig. 2).
The inversion spans the replication terminus from gmhB to
clpB. The inversion was apparent from long Pacific Bio-
sciences (PacBio) reads and was generated by recombina-
tion between the equivalent DNA of the E. coli K-12 rrfH
and rrsG RNA genes. PCR was used to confirm this intra-
chromosomal recombination event. Amplification of E. coli
K-12 genomic DNA with primers corresponding to regions
within gmhB and dkgB resulted in a product of 6.8 kb. No
amplification product could be detected from similar reac-
tions with E. coli NCTC 86 genomic DNA (Fig. 2). In con-
trast, PCR amplification of E. coli NCTC 86 genomic DNA
with primers corresponding to regions within gmhB and
kgtP resulted in a product of 7.2 kb, while no PCR product
was obtained from reactions with the same primers and
E. coli K-12 DNA (Fig. 2). The size of the PCR products
observed in these experiments is consistent with the dis-
tance between these genes predicted from the genome
sequence data. The absence of an amplification product
indicates that the target genes are located distally on the
chromosome. Whilst these results confirm the inversion,
the functional significance of this recombination event is
unknown. This phenomenon has been noted before to occur
in laboratory strains, but it was suggested that strains with
such inversions rarely survive in the environment [10]. The
inversion in E. coli NCTC 86 may have arisen due to
prolonged culture and storage under laboratory conditions.
However, such inversions have been noted in strains more
recently isolated from humans [11].
Phylogeny of E. coli NCTC 86
The phylogeny of E. coli NCTC86 was resolved through
comparisons with the genome sequences of other E. coli and
Shigella strains. The core genome was used to reconstruct a
phylogenetic tree (Fig. 3), with Escherichia albertii and
Escherichia fergusonii included as outgroups. As previously
noted, the E. coli subgroups A, B1, B2, D and E are all
monophyletic, with the exception of group D; group D is
divided at the root [12]. E. coli NCTC 86 is located in the A
subgroup and clusters closely with the non-pathogenic labo-
ratory strains of E. coli K-12. E. coli K-12 is considered a
commensal derivative on the basis that it was isolated from
a patient with diphtheria and without diarrhoeal disease or
urinary tract infections [13]. Thus, the location of E. coli
NCTC 86 close to E. coli K-12 is consistent with Escherich’s
observations of a non-pathogenic organism that was part of
the normal microbiota [7].
A recurrent issue in the field of E. coli biology has been the
assumption that E. coli K-12 represents an ancestral evolu-
tionary lineage of the species. This misplaced belief probably
arose from the fact E. coli K-12 was an early isolate of the
species. Further confusion arises when the genomes of path-
ogenic E. coli are considered: E. coli K-12 is often used as a
baseline genome with the simplistic view that pathogens are
E. coli K-12 derivatives that have acquired extra DNA
encoding disease-causing functions. These observations
have been challenged before [14], and are again challenged
here. Despite their early isolation, it is clear from their phy-
logenetic distribution that neither E. coli K-12 nor E. coli
NCTC 86 represents an ancestral state for the species.
Indeed, the observation that these strains are distant from
the root, and the smaller size of their genetic complement,
suggest these strains are undergoing reductive evolution as
they transition to a state of commensalism. Similar reductive
evolution has been noted for many intracellular obligate
Table 1. Major features of the genome of E. coli NCTC 86 and several archetypal E. coli strains
Characteristic E. coli strain
NCTC 86 MG1655 O157 :H7 E24377A 042 CFT073
Aetiology Commensal Laboratory EHEC ETEC EAEC UPEC
Size (bp) 5 144 392 4 641 652 5 594 477 5 249 288 5 241 977 5 231 428
Plasmids None None pO157, pOSAK1 pETEC_5, pETEC_6,
pETEC_35, pETEC_73,
pETEC_74, pETEC_80
pAA None
Predicted CDSs 4805 4377 5292 4991 4810 5533
G+C mol% 50.6 51.1 50.4 50.6 50.56 50.47
tRNA 69 86 103 63 93 89
rRNA 22 22 22 22 22 22
EAEC, Enteroaggregative E. coli; EHEC, enterohaemorrhagic E. coli; ETEC, enterotoxigenic E. coli.
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organisms as they shed their free-living lifestyles in favour
of a less competitive existence in a host-restricted environ-
ment [15, 16]. Genetic attrition can also be observed for
E. coli NCTC 86. For example, the locus encoding ETT2
(ROD 24), a cryptic type 3 secretion system (T3SS), appears
to be intact in E. coli strains O157 :H7 and 042, but like
other E. coli strains, the locus is severely eroded in E. coli
NCTC 86 (Fig. S1). In a similar manner, the majority of the
locus encoding Flag-2, a cryptic lateral flagellum found in
E. coli 042 and UMN026, is absent in E. coli NCTC 86 (Fig.
S2). Such observations support the hypothesis that E. coli
NCTC 86 is a modern rather than an ancestral lineage of
E. coli.
Comparative genomics of E. coli NCTC 86
As previously stated, phylogenetic mapping revealed E. coli
NCTC 86 is located in the A subgroup along with the
non-pathogenic laboratory strain E. coli K-12 and the com-
mensal isolate E. coli HS. Comparison of E. coli NCTC 86
with the closely related E. coli K-12 and HS strains
revealed that these chromosomes are largely similar, with
3640 genes conserved in all three strains (Fig. 4). Analyses
of the gene contents of all three strains revealed that E. coli
NCTC 86 contains 789 CDSs that are not present in the
other two non-pathogenic strains. The majority (54%) of
these genes are predicted to encode transposons, integra-
ses, prophage genes and other mobility factors or
1 000 000
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O-antigen
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Fig. 1. Circular representation of the E. coli NCTC 86 chromosome. From the outside to inside, circle 1 shows the sizes in bp. Circle 2
marks the positions of RODs. Circles 3 and 4 show the positions of CDSs transcribed in a clockwise and anticlockwise direction. Circles
5 to 10 show the positions of E. coli NCTC 86 genes that have orthologues (by reciprocal FASTA analysis) in other E. coli strains: K-12
MG1655 (red), E24377A (ETEC; yellow), 042 (ETEC; green), Sakai (0157 : H7; blue), IAI39 (Extraintestinal Pathogenic E. coli; pink), CFT073
(UPEC; orange). Circle 11 shows a plot of G+C content. Circle 12 shows a plot of G+C skew.
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hypothetical proteins that are located throughout the chro-
mosome. These 601 CDSs are contained in RODs distrib-
uted across the genome: they are discussed in the sections
below. E. coli HS and NCTC 86 share 104 common genes
not present in E. coli K-12, the majority of which encode
hypothetical proteins. The rest contain a variety of genes,
such as a type 6 secretion system (T6SS) NCTC86_02960–
76. In contrast, there are 272 genes present in E. coli K-12
and NCTC 86 not found in E. coli HS. Around half of
these are genes of unknown function; the rest are an
assortment of genes such as the fecABCDEIR genes, which
encode a ferric citrate uptake system, and the wcaABC-
DEFGHIJKLMN genes, which encode proteins involved in
colanic acid synthesis. Additionally, E. coli HS and K-12
contain 57 genes not found in E. coli NCTC 86, over half
of which consist of genes of unknown function or mobile
elements. The rest are an assortment of genes such as the
cold shock protein genes, cspBSHI, and the antibiotic-resis-
tance genes, such as acrR and blr (Table S2). E. coli K-12
contains 408 genes not present in either E. coli NCTC 86
or HS. Again, most of these are mobile elements.
Serotype antigens
Three major structures associated with the cell envelope of
Gram-negative bacteria are flagella, lipopolysaccharide
(LPS) and capsular polysaccharide (CPS), which mediate
motility and protect the organism by providing a barrier to
noxious substances and components of the immune system,
respectively. The flagella, LPS and CPS are the three major
antigenic determinants of E. coli: named the H-, O- and K-
antigens, respectively. These structures can demonstrate
high degrees of polymorphism that give rise to differences
yfiHclpBdkgByfaC
yfiHclpBrrsGrrlGrrfGkgtPyfiM
yfiMkgtPNCTC86_00220metN
dkgBrrfHmetN rrsH
NCTC86_02992
yfaC
gmhB
gmhB
Primer 3
Primer 1
Primer 2
Primer 1
NCTC 86 MG1655
8000
6000
Primers 1 and 2
NCTC 86 MG1655
8000
6000
Primers 1 and 3
NCTC 86
MG 1655
Fig. 2. Global comparison between of the chromosomes of E. coli NCTC 86 and E. coli K-12 MG1655. The red bars between the DNA
lines represent individual TBLASTX matches, with inverted matches coloured blue. Regions where inversion occurs have been expanded,
with RNA genes in green, backbone flanking regions in purple, and either side of the inversion in blue and orange. The products arising
from PCR amplification of genomic DNA with primers corresponding to gmhB (primer 1) and dkgB (primer 2) or kgtP (primer 3) were
separated by agarose gel electrophoresis and are shown in insets; sizes (bp) are shown on the left of the gel images.
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in antigenicity. This polymorphism has been exploited for
many years for the serological detection and typing of E. coli
isolates [17].
Flagellin (FliC) is the major protein subunit of the flagellum.
Amino acid variation in flagellin is responsible for changes
to the antigenic profile of the flagellum. Examination of the
E. coli NCTC 86 genome sequence revealed the that major
flagellar locus encodes an H10-serotype flagellin subunit
that is identical to the flagellar locus of E. coli Bi 623–42, an
O11 : H10 strain isolated from a patient with peritonitis
[18]. This is consistent with the detection of the H10 flagel-
lin reported for E. coli NCTC 86 [19].
Smooth LPS is a repeating structure termed the O-antigen
side chain polysaccharide, which is chemically linked to
the core oligosaccharide. The core oligosaccharide is fur-
ther divided into the inner and outer core. In E. coli, the
genes encoding the lipid A-core oligosaccharide and the
O-antigen polysaccharide portions of LPS are encoded
separately on the chromosome and are synthesized by
independent pathways before linkage at the inner mem-
brane [20]. The inner core and lipid A portions of the
molecule are highly conserved. The outer core exhibits
variation giving rise to five different core oligosaccharide
structures designated K-12, R1, R2, R3 and R4. Inspection
of the E. coli NCTC 86 genome revealed a locus (ROD 37)
Fig. 3. Phylogenetic relationships amongst sequenced E. coli genomes. The genomes of E. albertii and E. fergusonii are included as out-
group sequences. The tree was obtained by maximum likelihood analysis of a concatenated alignment of 2173 genes, using the gen-
eral time reversible (GTR/REV) model, with the CAT approximation of rate heterogeneity as implemented in RAxML version 8.1.3. The
numbers on individual branches indicate the percentage support from 100 non-parametric bootstrap replicates, performed using the
rapid algorithm implemented in RAxML. T he branch length indicates the number of substitutions per site. The major E. coli phyloge-
netic groups are indicated.
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encoding an R2 oligosaccharide core. This locus is 99%
identical over 8 kb to the R2 prototype strain E. coli F632,
which is an O-antigen-deficient derivative of E. coli
100 : K?(B) : H2 [21]. The biological significance of the R2
core is unknown: it is the least frequently occurring core
type amongst commensal and pathogenic E. coli [22].
However, the presence of an R2 oligosaccharide core in a
commensal organism suggests that efforts to target vac-
cines to this core region might be unwise, as it might neg-
atively impact on the ability of a commensal organism to
colonize the gut [23].
In striking contrast to the lipid A-core components, the O-
antigens of LPS are chemically and structurally diverse.
Over 180 serologically distinct O-antigens have been identi-
fied in E. coli [24]. Scrutiny of the E. coli NCTC 86 genome
revealed a locus encoding the proteins to produce an O-
antigen of serotype O15 (ROD 4). This locus is 99% identi-
cal to the nucleotide sequence of the O-antigen locus from
E. coli G1201 (O15 : K14 : H4) over 9.2 kb. Analysis of the
O-antigen-encoding locus revealed that the E. coli NCTC 86
locus is 2.3 kb smaller than the E. coli G1201 locus. This
deletion appears to have occurred through recombination of
the ISE3C element with the wzy gene, which encodes the O-
antigen polymerase, resulting in truncation of wzy and loss
of the wzx and wbuS genes encoding the O-antigen flippase
and a glycosyltransferase, respectively [25–27]. The loss
of O-antigen expression in E. coli is a common feature of
strains cultured in the laboratory for extended periods of
time [28, 29].
Capsules are a series of high-molecular-mass polysacchar-
ides that coat the bacterial surface. They are widely distrib-
uted and are found in many diverse pathogens such as
Neisseria meningitidis, Staphylococcus aureus, Streptococcus
pneumoniae and E. coli. At least 80 different polysaccharide
capsules have been identified in E. coli. They have been sep-
arated into four different types (groups 1–4) based on their
genetic organization, as well as their physical and biochemi-
cal properties [30]. E. coli NCTC 86 possesses the kps locus
on ROD 31 (Fig. S3). The arrangement of the kpsFEDUCS
capsular biosynthesis genes in region I and the ABC trans-
porter genes kpsMT in region III are consistent with the
production of group 2 CPS. The variable region II, which is
the determinant of antigenicity, is 98% identical to the
genes in region II of E. coli CFT073 (Fig. S3). This suggests
that the E. coli NCTC 86 kps locus encodes a K-2 serotype
capsule. Such capsules are often associated with strains that
cause extra-intestinal infection, where they provide protec-
tion against complement-mediated killing. However, as
commensals do not need to evade the immune system, it
might play a role in protection in the environment, such as
desiccation.
Metal binding and resistance
Iron plays an essential role in metabolic and cellular pro-
cesses, in particular acting as a cofactor for several critical
enzymes [31]. However, free iron is not readily available. In
an aqueous environment at physiological pH it forms insol-
uble Fe(OH)3. Pathogens and commensals encounter addi-
tional problems in vivo as iron is extensively chelated by
host proteins, such as ferritin and lactoferrin [32]. Thus,
bacteria require efficient iron-acquisition mechanisms in
order to survive. Some bacteria secrete molecules termed
siderophores that have high affinity for iron. The iron-
bound forms of the siderophore are recognized by specific
proteinaceous machines that facilitate their uptake into the
bacterial cell [33]. E. coli NCTC 86 possesses a locus, located
on ROD 5, which encodes the siderophore yersiniabactin
(Ybt) (Fig. S4). Ybt was first described in Yersinia, but it is
widespread amongst the Enterobacteriaceae [34]. The E. coli
NCTC 86 locus is most similar to the E. coli 042 locus (97%
identity over 24 kb). Interestingly, in addition to the
reported iron-acquisition functions of Ybt, some studies
suggest that Ybt contributes to bacterial resistance to copper
[35]. Copper ions have been shown to be toxic to E. coli [36,
37]. Therefore, Ybt might act as a countermeasure to copper
toxicity by sequestering host-derived copper and preventing
its catechol-mediated reduction to copper (I), this enables
bacteria to proliferate in vivo and can confer protection
from redox-based phagocytic defences [38].
Like copper, silver ions show antibacterial activity against
E. coli. Interestingly, E. coli NCTC 86 harbours a 36 kb locus
(sil) comprised of nine ORFs (ROD36) that are associated
with silver resistance (Fig. S5). The sil locus confers resis-
tance though a sliver ion efflux system. Although the sil
locus is frequently found on plasmids harbouring antibi-
otic-resistance genes, such as the pMG101 plasmid [39], in
272104
3640
40857719
789
E. coli NCTC 86 
E. coli K-12 MG1655 E. coli HS 
Fig. 4. Comparison of the genetic content of E. coli NCTC 86 with other
genome-sequenced E. coli. The three strains belong to the same phylo-
genetic group (group A) and share 3640 common genes. E. coli HS and
NCTC 86 share 104 genes that are not present in E. coli K-12. Simi-
larly, E. coli K-12 has 272 genes in common with E. coli NCTC 86 that
are absent in E. coli HS. E. coli HS and K-12 share 57 genes that are
absent from E. coli NCTC 86. All strains possess a complement of
unique genes not present in the other strains; there are 789 genes
present in E. coli NCTC 86 not present in E. coli K-12 or E. coli HS, 719
genes present in E. coli HS not present in E. coli K-12 and NCTC 86,
and 408 genes in E. coli K-12 not found in E coli HS or NCTC 86.
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E. coli NCTC 86 it was found on the chromosome. The
locus had a similar genetic arrangement to E. coli C
ATCC8739, H10407 and in E. coli 55989, Enterobacter cloa-
cae ATCC 13047 and Cronobacter sakazakii CMCC 45402
(Fig. S5), where it is also found on the chromosome. It was
suggested that this locus was only recently acquired by
E. coli after the introduction of silver nanoparticles as an
antibacterial agent. This hypothesis was based on the obser-
vation that E. coli strains recently isolated from humans
possessed the sil locus, but that no E. coli strain of an avian
origin was found to contain the locus [40]. However, E. coli
NCTC 86 clearly acquired this locus before the current
widespread use of silver nanoparticles, suggesting there is
an alternative explanation for the appearance of this locus
in human isolates. It is tempting to speculate that the reason
E. coli NCTC 86 possesses the sil locus was the widespread
use of silver utensils and currency in Germany in the 1800s.
Metabolism
The metabolic properties encoded in a bacterium are one of
the primary factors in determining whether it is successful
in an ecological niche. E. coli NCTC 86 contains a variety of
RODs encoding loci associated with metabolic functions,
such as ethanolamine utilization, a set of acyl-CoA synthe-
tase and permease genes, and putative C4-dicarboxylate and
sugar-uptake systems.
The phosphotransferase system (PTS) is a translocation sys-
tem that transports a variety of different sugars into the cell.
The PTS consists of two proteins, an enzyme I and HPr, and
a number of carbohydrate-specific enzymes, the enzymes II.
In addition to the PTSs encoded in the conserved core E. coli
genes, E. coli NCTC 86 possesses two sugar-uptake systems
encoded on RODs. The vpe locus is located on ROD 40 and is
99.77% identical to the vpe locus of E. coli O104 :H4 2009EL-
2050 strain. The vpe operon was first described in the
uropathogenic E. coli (UPEC) strain AL511 in which mutants
were shown to produce much smaller amounts of group two
capsule [41]. As noted earlier, E. coliNCTC 86 encodes a sim-
ilar group two capsule. ROD 40 also contains the deoK
operon. This region conferring the ability to utilize deoxyri-
bose as a carbon source is thought to have been transferred
from Salmonella enterica to E. coli [42]. The deoK operon is
commonly connected with strains isolated from infected
blood and urine, in which it is usually found in extensive
islands carrying genes contributing to the adaptive properties
and/or virulence of UPEC strains, such as the sepsis strain
E. coli AL862 [43]. The second putative PTS is located on
ROD 34 of E. coli NCTC 86 and is 98% identical to that in E.
coli O157 :H7 Sakai. However, the function of this system is
unknown.
E. coli NCTC 86 contains a putative C4-dicarboxylate uptake
(Duc) transporter system located on ROD 30 that is com-
posed of three genes clustered together: a tripartite ATP-
independent periplasmic (TRAP) transporter; an ABC
transporter permease; and a substrate-binding protein. E.
coli NCTC 86 system is 100% identical to the C4-dicarboxy-
late system found in E. coli IAI39. However, in E. coli IAI39
there is a transposon inserted in the centre of the periplas-
mic (TRAP) transporter gene, indicating that it might not
be functional in this isolate. While many bacteria utilize
molecules such as aspartate, malate, fumarate and succinate
for anaerobic respiration (aspartate is metabolized under
both aerobic and anaerobic conditions), the function and
substrate of this specific C4-dicarboxylate uptake system
remains unknown.
Protein secretion systems
Protein secretion involves translocation across the cyto-
plasmic membrane, and in Gram-negative bacteria the addi-
tional barriers of a peptidoglycan-filled periplasm and an
outer membrane. To combat these latter obstacles, Gram-
negative bacteria have evolved a number of highly special-
ized protein secretion systems [44]. Inspection of the E. coli
NCTC 86 genome revealed loci encoding a type 1 secretion
system (T1SS), type 2 secretion system (T2SS), T3SS, type 5
secretion system (T5SS) and a T6SS. The ETT2 and Flag-2
T3SSs were discussed earlier.
Conventional T1SSs of Gram-negative bacteria are com-
posed of a secreted substrate protein and three envelope-
associated subunits: a TolC-like outer membrane pore-
forming protein (OMP), and two inner-membrane-associ-
ated proteins, termed the ATP-binding cassette (ABC) pro-
tein, which provide energy to the system, and the
membrane-fusion protein (MFP), which contacts with the
TolC-like protein to form the secretion channel across the
cell envelope on ROD 17 [45]. Like the conventional sys-
tems, the E. coli NCTC 86 system possesses an OMP
(NCTC86_02172), MFP (NCTC86_02173) and ABC protein
(NCTC86_02170). In contrast to the conventional T1SSs,
the locus also encodes an additional ABC protein
(NCTC86_02173) and an
additional component whose function is unknown
(NCTC86_02170) (Fig. S6). Unlike the conventional T1SS,
in which the C-terminal sequence is uncleaved, the putative
substrate molecules for the unconventional systems possess
an N-terminal Sec-dependent signal sequence that is
cleaved. Located downstream of the genes encoding the
translocation machinery is a pseudogene that would have
encoded a substrate molecule (NCTC86_02180) but is dis-
rupted by the insertion of genes encoding transposases.
However, located 11.2 kb upstream is NCTC86_02122,
which appears to encode a complete putative substrate mol-
ecule. This secretion system is homologous to the Aat/dis-
persin previously described for enteroaggregative E. coli
042. In E. coli 042, the substrate molecule is localized to the
bacterial cell surface where it promotes fimbrial-mediated
adherence by altering the surface charge of the bacterium
[46]. The presence of this gene cluster in a commensal bac-
terium suggests its primary role is in colonization rather
than in pathogenesis as previously suggested [47].
Several pathogenic strains of E. coli possess a chromosom-
ally encoded T2SS. For enterotoxigenic E. coli it is essential
for secretion of heat-labile enterotoxin (LT) [48]. In E. coli
K-12, the locus has undergone genetic attrition. It contains
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yghJ–gspO (pppA) – gspC (yghF) and the distal gspL–gspM
genes, but not the remainder of the T2SS (Fig S7). E. coli
NCTC 86 also possesses the distal gspL–gspM genes. How-
ever, the T2SS locus appears to be in an even later stage of
genetic attrition. The yghJGF and pppA genes have also been
lost. The erosion of this locus is further evidence for the
adaptation of E. coli NCTC 86 to a commensal lifestyle.
T5SSs are a large and diverse superfamily of proteins. Based
on structural differences and variations in the mode of bio-
genesis, T5SS has been divided into five subclasses: classical
autotransporters (T5aSS); the two-partner secretion systems
(T5bSS); the trimeric autotransporters (T5cSS); the chimeric
autotransporters (T5dSS); and the inverted autotransporters
(T5eSS). E. coli NCTC 86 does not appear to possess mem-
bers of the T5bSS, T5cSS or T5dSS subfamilies. However,
E. coli NCTC 86 possesses 15 loci encoding polypeptides
with homology to the T5aSS subfamily and 3 polypeptides
with homology to the T5eSS subfamily (Fig S8). Of the 15
T5aSS-encoding loci, 9 are found in E. coli K-12 and are
scattered throughout the chromosome; 4 of these are pseu-
dogenes. Remarkably, E. coli NCTC 86 possesses five loci
(NCTC86_00823, NCTC86_02105, NCTC86_02886, NCTC
86_03415 and NCTC86_04998) encoding polypeptides with
homology to the autotransporter antigen 43. These loci are
found on RODs 5, 17, 21, 31 and 41, although one (ROD 31;
NCTC86_03415) is a pseudogene. These classical autotrans-
porters have been implicated in adherence and biofilm for-
mation. The three loci encoding members of the T5eSS
subfamily can also be found in E. coli K-12. This family of
proteins has been implicated in mediating attachment to
host cells [49]. Scrutiny of the distribution of the T5SS genes
across the evolutionary spectrum of E. coli reveals no strong
association of these genes with pathogenic or non-patho-
genic isolates. This suggests that they do not play a specific
Fig. 5. Genetic architecture and distribution of the CU systems of E. coli NCTC 86. Phylogenetic distribution of the fimbrial loci amongst
pathogenic and non-pathogenic lineages of E. coli. The loci encoding the fimbrial systems demonstrate a differential distribution
amongst the E. coli phylogeny. The branch lengths indicate the number of substitutions per site.
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role in pathogenesis but rather promote colonization, a
function that is consistent with their presence in a commen-
sal strain.
E. coli NCTC 86 contains a T6SS. This locus encodes the
Hcp and Vgr proteins that form a needle-like injection
device and are essential for the T6SS to function. The locus
also contains the TssA, E, F, G and K core component pro-
teins. It is this type of T6SS that is most widespread amongst
E. coli [50–52]. This 30 kb locus is located on ROD 22 and
is >97% identical to the T6SS of E. coli 55989, and is highly
homologous to loci in E. coli 042, urinary tract isolates
UMN026, 536 and UTI89, and avian isolates APEC O1
(Fig. S9). T6SSs have been shown to be widespread among
the proteobacteria and have roles in inhibiting eukaryote
cell division as well as possessing antibacterial properties, by
acting as a mechanism to attack other bacterial cells [53].
Therefore, it is likely the locus provides E. coli NCTC 86
with a colonization advantage within the host.
Proteobacteria use chaperone–usher (CU) pathways to
assemble fimbriae on the bacterial surface. The CU system
is divided into six subfamilies, designated a-, b-, g-, k-, p-
and s-fimbriae [54]. E. coli NCTC 86 contains 12 CU sys-
tems, 9 of which are also present in E. coli K-12 (Fig. 5). It
lacks members of the k-, b- or s- subfamilies. As in E. coli
K-12, these CU operons appear to be scattered throughout
the chromosome. The other three CU systems in E. coli
NCTC 86 (NCTC86_00020–6, NCTC86_03382–8 and
NCTC86_02125–9) are found on RODs 1, 17 and 31,
respectively. The CU system encoded on ROD 1 is homolo-
gous to the mat fimbriae of E. coli O157, but the first gene
in this locus is truncated in E. coli NCTC 86 rendering the
system non-functional. The CU locus on ROD 31 is dis-
rupted by the insertion of two transposable elements and is
unlikely to be functional. The locus on ROD 17 also encodes
a non-functional CU system with homology to the aggrega-
tive adherence fimbriae of E. coli 042. There is no obvious
phylogenetic signature for the presence or absence of the
CU systems. Furthermore, there is no obvious association
with pathogenic or non-pathogenic lineages, with the excep-
tion of shigellae, which appear to have lost many of the loci
encoding these CU systems. As with the T5SS, these data
suggest that the CU systems do not play a specific role in
pathogenesis, but rather promote colonization. The diver-
sity of systems may allow colonization of different hosts or
colonization of different niches within the same host.
Conclusions
The complete genetic content of E. coli NCTC 86 described
in this article provides a modern interpretation for observa-
tions made by Escherich over 125 years ago. During the
preparation of this manuscript, a draft sequence of the same
strain and its historical provenance were reported [55].
These studies demonstrate that E. coli NCTC 86 is phyloge-
netically closely related to other commensal E. coli strains.
The anthropocentric view of bacteriology has largely driven
the study of pathogenic E. coli at the expense of understand-
ing commensalism and, perhaps, of truly understanding the
repertoire of genes that are required for pathogenesis and
those which are simply required for colonization. The cur-
rent study adds to the body of literature underpinning the
study of commensal E. coli and hints that these organisms
arose by reductive evolution as they adapted to an intimate
life with their mammalian hosts. However, given the plastic-
ity of the E. coli genome, further genomic studies are essen-
tial to determine those factors that are widely conserved for
commensal E. coli from geographically diverse locations and
distinctive human populations. With such studies, E. coli
will undoubtedly remain as a model organism.
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